Literature DB >> 18521895

Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA.

Hyejung Mok1, Tae Gwan Park.   

Abstract

A novel self-crosslinked and reducible peptide was synthesized for stable formation of nanoscale complexes with an siRNA-PEG conjugate to enhance transfection efficiency in serum containing condition without compromising cytotoxicity. A fusogenic peptide, KALA, with two cysteine residues at both terminal ends was crosslinked via disulfide linkages under mild DMSO oxidation condition. The reducible crosslinked KALA (cl-KALA) was used to form nano-complexes with green fluorescent protein (GFP) siRNA. Size and morphology of various polyelectrolyte complexes formulated with KALA and cl-KALA were comparatively analyzed. cl-KALA exhibited more reduced cell cytotoxicity and formed more stable and compact polyelectrolyte complexes with siRNA, compared with naked KALA and polyethylenimine (PEI), probably because of its increased charge density. The extent of gene silencing was quantitatively evaluated using MDA-MB-435 cells. cl-KALA/siRNA complexes showed comparable gene silencing efficiency with those of cytotoxic PEI. In a serum containing medium, cl-KALA/siRNA-PEG conjugate complexes exhibited superior gene inhibition because of the shielding effect of PEG on the surface. The formulation based on the self-crosslinked fusogenic peptide could be used as a biocompatible and efficient nonviral carrier for siRNA delivery. (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18521895     DOI: 10.1002/bip.21032

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  22 in total

1.  Bioreducible polymers for gene delivery.

Authors:  Tae-Il Kim; Sung Wan Kim
Journal:  React Funct Polym       Date:  2011-03-01       Impact factor: 3.975

2.  pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.

Authors:  Hyejung Mok; Omid Veiseh; Chen Fang; Forrest M Kievit; Freddy Y Wang; James O Park; Miqin Zhang
Journal:  Mol Pharm       Date:  2010-09-14       Impact factor: 4.939

3.  Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing.

Authors:  Hyejung Mok; Soo Hyeon Lee; Ji Won Park; Tae Gwan Park
Journal:  Nat Mater       Date:  2010-01-24       Impact factor: 43.841

Review 4.  Self-assembled and nanostructured siRNA delivery systems.

Authors:  Ji Hoon Jeong; Tae Gwan Park; Sun Hwa Kim
Journal:  Pharm Res       Date:  2011-03-18       Impact factor: 4.200

5.  Diseases originate and terminate by genes: unraveling nonviral gene delivery.

Authors:  Rajan Swami; Indu Singh; Wahid Khan; Sistla Ramakrishna
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

Review 6.  Exploring the role of polymer structure on intracellular nucleic acid delivery via polymeric nanoparticles.

Authors:  Corey J Bishop; Kristen L Kozielski; Jordan J Green
Journal:  J Control Release       Date:  2015-10-01       Impact factor: 9.776

7.  N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery.

Authors:  Gang Liu; Jin Xie; Fan Zhang; Zhiyong Wang; Kui Luo; Lei Zhu; Qimeng Quan; Gang Niu; Seulki Lee; Hua Ai; Xiaoyuan Chen
Journal:  Small       Date:  2011-08-22       Impact factor: 13.281

Review 8.  Nanomaterials for cancer therapy and imaging.

Authors:  Ki Hyun Bae; Hyun Jung Chung; Tae Gwan Park
Journal:  Mol Cells       Date:  2011-02-25       Impact factor: 5.034

Review 9.  Aptamer and its applications in neurodegenerative diseases.

Authors:  Jing Qu; Shuqing Yu; Yuan Zheng; Yan Zheng; Hui Yang; Jianliang Zhang
Journal:  Cell Mol Life Sci       Date:  2016-08-25       Impact factor: 9.261

Review 10.  Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules.

Authors:  Robert K Delong; Christopher M Reynolds; Yaneika Malcolm; Ashley Schaeffer; Tiffany Severs; Adam Wanekaya
Journal:  Nanotechnol Sci Appl       Date:  2010-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.